Jazz Pharmaceuticals
JAZZ
JAZZ
319 hedge funds and large institutions have $8.31B invested in Jazz Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 114 increasing their positions, 103 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 306 → 319 (+13)
1.38% more ownership
Funds ownership: 87.52% → 88.9% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
Holders
319
Holding in Top 10
11
Calls
$80.3M
Puts
$68.4M
Top Buyers
| 1 | +$135M | |
| 2 | +$132M | |
| 3 | +$124M | |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$77.4M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$71.2M |
Top Sellers
| 1 | -$125M | |
| 2 | -$99.7M | |
| 3 | -$89.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$53.5M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$27.9M |